LIXTE Biotechnology allocates 25% of its funds to Crypto Assets including Bitcoin.

[Coin World] Nasdaq-listed company LIXTE Biotechnology announced that its board of directors has approved a strategic capital allocation plan to acquire Crypto Assets as part of the company's funding. The board also approved allocating 25% of the funds to Crypto Assets, including Bitcoin and other potential digital assets (as appropriate).

BTC-4%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 7
  • Repost
  • Share
Comment
0/400
rugpull_ptsdvip
· 4h ago
Another new sucker gets on board
View OriginalReply0
BlockchainDecodervip
· 14h ago
According to reference data, the asset allocation ratio of Nasdaq Biotech is too aggressive. It is recommended to reduce it to 15-20%.
View OriginalReply0
NFTArtisanHQvip
· 08-13 12:50
fascinating intersection of corporate hegemony and digital sovereignty tbh...
Reply0
ExpectationFarmervip
· 08-13 12:48
Haha, another one is ready to Be Played for Suckers.
View OriginalReply0
NightAirdroppervip
· 08-13 12:46
Another pro has jumped into the crypto world to play people for suckers.
View OriginalReply0
BlockchainRetirementHomevip
· 08-13 12:35
Whose 25% is this? So fierce!
View OriginalReply0
SandwichHuntervip
· 08-13 12:30
This wave of Coin Hoarding is very reliable.
View OriginalReply0
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)